Utility values in Japanese patients with exudative age-related macular degeneration

Japanese Journal of Ophthalmology

Volumn 55, Issue 1, 2011, Pages 35-38

  Yanagi, Yasuo ^a   Ueta, Takashi ^a   Obata, Ryo ^a   Iriyama, Aya ^a   Fukuda, Takashi ^b   Hashimoto, Hideki ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

age related macular degeneration; quality of life; utility value

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST UTILITY ANALYSIS; DISEASE SEVERITY; EXUDATIVE MACULAR DEGENERATION; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GENERAL CONDITION DETERIORATION; HUMAN; JAPANESE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; SOCIOECONOMICS; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; COST-BENEFIT ANALYSIS; EXUDATES AND TRANSUDATES; FEMALE; FUNCTIONAL LATERALITY; HUMANS; JAPAN; MACULAR DEGENERATION; MALE; MIDDLE AGED; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SICKNESS IMPACT PROFILE; VISION DISORDERS; VISUAL ACUITY;

EID: 79952297164     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-010-0893-y     Document Type: Article

References (17)

1. R. Kawasaki J.J. Wang G.J. Ji, et al. 2008 Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study Ophthalmology 115 1376 1381 10.1016/j.ophtha.2007.11.015 18222000
2. G.C. Brown M.M. Brown H.C. Brown S. Kindermann S. Sharma 2007 A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration Ophthalmology 114 1170 1178 10.1016/j.ophtha.2006.09.019 17320964 (Pubitemid 46829369)
3. G.C. Brown S. Sharma M.M. Brown J. Kistler 2000 Utility values and age-related macular degeneration Arch Ophthalmol 118 47 51 1:STN:280: DC%2BD3c7gtVelug%3D%3D 10636413 (Pubitemid 30036436)
4. S. Sharma G.C. Brown M.M. Brown H. Hollands G.K. Shah 2001 The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration Ophthalmology 108 2051 2059 1:STN:280:DC%2BD3MnmvVKmtg%3D%3D 10.1016/S0161-6420(01)00764-3 11713079 (Pubitemid 33032778)
5. M.M. Brown G.C. Brown H.C. Brown J. Peet 2008 A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration Ophthalmology 108 1039 1045 10.1016/j.ophtha.2007.08.033 (Pubitemid 351749692)
6. J. Karnon C. Czoski-Murray K. Smith, et al. 2008 A preliminary modelbased assessment of the cost-utility of a screening programme for early age-related macular degeneration Health Technol Assess 12 iii iv 1:STN:280: DC%2BD1czltVKkuw%3D%3D
7. C. Meads C. Salas T. Roberts D. Moore A. Fry-Smith C. Hyde 2003 Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation Health Technol Assess 9 v vi
8. C. Hopley G. Salkeld P. Mitchell 2004 Cost utility of photodynamic therapy for predominantly classic neovascular age-related macular degeneration Br J Ophthalmol 88 982 987 1:STN:280:DC%2BD2czlsVyjtQ%3D%3D 10.1136/bjo.2003. 039131 15258009 (Pubitemid 39013134)
9. Y. Suzukamo T. Oshika M. Yuzawa, et al. 2005 Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version Health Qual Life Outcomes 3 65 10.1186/1477-7525-3-65 16248900 (Pubitemid 41601347)
10. T. Ueta R. Obata Y. Inoue, et al. 2009 Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmology 116 2400 2406 10.1016/j.ophtha.2009.06.013 19815291
11. K. Saito T. Yamamoto D. Tsuchiya R. Kawasaki S. Haneda H. Yamashita 2009 Effect of combined treatment with sub-Tenon injection of triamcinolone acetonide and photodynamic therapy in Japanese patients with age-related macular degeneration Jpn J Ophthalmol 53 512 518 1:CAS:528:DC%2BD1MXhtlSlt7rP 10.1007/s10384-009-0703-6 19847608
12. N. Bansback S. Davis J. Brazier 2007 Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration Eye 21 1455 1463 1:CAS:528: DC%2BD1cXhtFWitA%3D%3D 10.1038/sj.eye.6702636 17086167
13. M. Espallargues C.J. Czoski-Murray N.J. Bansback, et al. 2005 The impact of age-related macular degeneration on health status utility values Invest Ophthalmol Vis Sci 46 4016 4023 10.1167/iovs.05-0072 16249475 (Pubitemid 44264600)
14. I. Maruko T. Iida M. Saito D. Nagayama K. Saito 2007 Clinical characteristics of exudative age-related macular degeneration in Japanese patients Am J Ophthalmol 144 15 22 10.1016/j.ajo.2007.03.047 17509509 (Pubitemid 46963198)
15. T. Ueta A. Iriyama J. Francis, et al. 2008 Development of typical agerelated macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration Am J Ophthalmol 146 96 101 10.1016/j.ajo.2008.03.002 18439567
16. S.M. Kymes B.S. Lee 2007 Preference-based quality of life measures in people with visual impairment Optom Vis Sci 84 809 816 10.1097/OPX. 0b013e3181337638 17700344 (Pubitemid 47262992)
17. G.C. Brown M.M. Brown H.C. Brown S. Kindermann S. Sharma 2007 The goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration Trans Am Ophthalmol Soc 105 160 169 18427606 (Pubitemid 352031792)